(Q28288610)

English

Rifaximin for the treatment of hepatic encephalopathy

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Rifaximin for the treatment of hepatic encephalopathy (English)

0 references

main subject

hepatic encephalopathy

1 reference

Kenneth R Lawrence

1

0 references

Jacqueline A Klee

series ordinal

2

0 references

language of work or name

English

0 references

publication date

August 2008

0 references

published in

Pharmacotherapy

0 references

volume

28

0 references

issue

8

0 references

page(s)

1019-32

0 references

cites work

Complications of cirrhosis III. Hepatic encephalopathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Hepatic Encephalopathy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Rifaximin in the treatment of chronic hepatic encephalopathy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.28.8.1019

retrieved

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.8.1019

0 references

PubMed publication ID

18657018

0 references

ResearchGate publication ID

51430091

0 references

(Q28288610)

Rifaximin for the treatment of hepatic encephalopathy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)